PillRx only · Tablet, Extended Release · Oral
Mirabegron
Mirabegron
3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
3 active makers
3 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$9.479
Latest avg · Jul 22, 2026
-2%
Since Dec 17, 2025
3
Active US suppliers
86%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
30K
Rx · 2026 Q1
1.2M
Units dispensed
-2%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Zydus Lifesciences Limited | unknown | 6 | SUPPLYING |
| Zydus Pharmaceuticals USA Inc. | unknown | 6 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 2 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.